论文部分内容阅读
目的探讨布地奈德联合硫酸特布他林雾化吸入治疗 COPD 的临床效果.方法选取收治的50例 COPD 急性加重期患者,随机分为观察组(20例)和对照组(30例 ),对照组在常规治疗基础上静脉滴注地塞米松注射液(前3天10 mg/d,第4-10天减半)和硫酸特布他林(0.25mg/次,2次/d).观察组在常规治疗基础上给予布地奈德混悬液1mg 加硫酸特布他林雾化液5mg,通过氧气驱动雾化吸入,2次/d.观察两组的临床效果.结果观察组20例中,显效16例,有效3例,无效1 例,总有效率为93.5%;对照组30例中,显效15例,有效 6例,无效9例,总有效率为70%.观察组疗效优于对照组,差异有统计学意义(P<0.05).结论布地奈德混悬液联合硫酸特布他林雾化吸入治疗 COPD 临床效果显著,值得临床应用.“,”ObjectiveDiscussion of budesonide combined with terbutaline sulfate aerosol inhalation in treatment of the clinical results of COPDMethodsSelection of 50 cases of acute exacerbations of COPD, were randomly divided into the observation group (20 cases) and control group (n = 30), the control group on the basis of routine treatment of intravenous dexamethasone injection (3 days before the 10 mg/d, the first 4-10 days half) and terbutaline sulfate (0.25mg/, 2 /d).The observation group in the conventional treatment based on the given budesonide suspension 1mg plus terbutaline sulfate aerosol solution 5mg, driven by the oxygen inhalation, 2 /d.Observation of clinical effects of two groupsResults The observation group 20 cases, effective in 16 cases, effective in 3 cases, ineffective in 1 cases, the total effective rate was 93.5%; the control group of 30 cases, 15 cases were markedly effective, effective in 6 cases, 9 cases are invalid, the total efficiency of 70%.The therapeutical effect of observation group was better than the control group, the difference was statisticaly significant (P ﹤ 0.05)ConclusionsBudesonide combined with terbutaline sulfate aerosol inhalation in treatment of COPD clinical effect, worthy of clinical application